Portuguese real-world experience with ibrutinib for the treatment of relapsed/refractory mantle cell lymphoma

BackgroundMantle cell lymphoma is usually characterized by an aggressive and recurrent course. Clinical trials and real-world series have demonstrated clinical benefits with the use of ibrutinib as a second-line treatment, compared to later relapses.ObjectiveTo evaluate the Portuguese experience wit...

Cijeli opis

Bibliografski detalji

Glavni autori:	Catarina Fernandes, Rita Costa e Sousa, Pedro Santos, Cátia Almeida, Adriana Roque, Ana Luísa Pinto, Joaquim Monteiro, Anabela Neves, Maria João Ramos, Rita Coutinho, Filipa Mousinho, Mariana Leal Fernandes, Margarida Badior, Cristina João, Sónia Leocádio, Ana Luísa Tomé, Margarida Carrolo, Sara Dias, Maria Gomes da Silva, João Paulo Fernandes
Format:	Artigo
Jezik:	Inglês
Izdano:	Frontiers Media S.A. 2025-11-01
Serija:	Frontiers in Hematology
Teme:	ibrutinib mantle cell lymphoma relapse/refractory disease real-world Portuguese
Online pristup:	https://www.frontiersin.org/articles/10.3389/frhem.2025.1702446/full
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!